In the previous study, we developed a novel nanoparticle vaccine by conjugating receptor binding domain (RBD) and heptad repeats (HR) of Spike onto a Ferritin-based 24-mer particle, which elicited potent immunogenicity in rhesus macaques and protected hACE2-mice from virus infection. The gene discussed is CHMP5; the disease is viral infectious disease.